<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00121927</url>
  </required_header>
  <id_info>
    <org_study_id>04-02-27-08</org_study_id>
    <nct_id>NCT00121927</nct_id>
  </id_info>
  <brief_title>Use of the Atkins Diet for Adults With Intractable Epilepsy</brief_title>
  <official_title>Use of the Atkins Diet for Adults With Intractable Epilepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <brief_summary>
    <textblock>
      This is a prospective study to determine whether the Atkins diet reduces seizures, creates
      ketosis, and is well tolerated in adults with epilepsy. Approximately 30 patients will be
      enrolled, expecting 20 to complete the 6-month study. The investigators plan to establish the
      seizure baseline and type, initiate the Atkins diet, then monitor its administration in terms
      of seizure reduction, ketosis, and side effects for a 6-month period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are seen in the Johns Hopkins General Clinical Research Center (GCRC) and started on
      a modified Atkins diet (15g/day of carbohydrates). Medications remain unchanged and labs are
      drawn. Followup is at 1 month, 3 months, and 6 months into the study. After 1 month,
      carbohydrates and medications can be altered. Ketosis (urine) is measured by patients
      semiweekly, weight weekly, and seizures daily and recorded on a calendar.

      This study is ongoing with approximately 20 patients of 30 enrolled as of February 2006.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date>June 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Seizure reduction</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ketosis</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tolerability</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Epilepsy</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Atkins diet (15 grams/day carbohydrates)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18 and over

          -  Weekly seizures or 4 times per month

          -  Use of at least 2 anticonvulsant drugs

        Exclusion Criteria:

          -  Prior use of the Atkins diet for &gt; 1 week

          -  Prior use of the ketogenic diet within the past year

          -  Kidney, heart disease, renal disease

          -  Hypercholesterolemia

          -  Pseudoseizures

          -  Pregnancy

          -  Body mass index (BMI) below 18.5

          -  Status epilepticus within the past 6 months

          -  2 week seizure-free period within the past 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric H Kossoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Hospital GCRC</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.hopkinsmedicine.org/neurology_neurosurgery/specialty_areas/epilepsy/</url>
    <description>Center website</description>
  </link>
  <link>
    <url>http://www.atkinsforseizures.com</url>
    <description>Patient support network (non-medical) website</description>
  </link>
  <reference>
    <citation>Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003 Dec 23;61(12):1789-91.</citation>
    <PMID>14694049</PMID>
  </reference>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2005</study_first_submitted>
  <study_first_submitted_qc>July 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2005</study_first_posted>
  <last_update_submitted>January 26, 2010</last_update_submitted>
  <last_update_submitted_qc>January 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2010</last_update_posted>
  <keyword>intractable</keyword>
  <keyword>ketogenic</keyword>
  <keyword>ketosis</keyword>
  <keyword>Atkins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

